The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin).
- 1 January 1997
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 34 (2) , 145-151
- https://doi.org/10.1023/a:1005743707803
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Modulation of IGF-2 expression during growth and differentiation of human neuroblastoma cells: Retinoic acid may induce IGF-2Neuroscience Letters, 1993
- Retinoids and Cancer TherapyJNCI Journal of the National Cancer Institute, 1992
- Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final reportInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Inhibition of growth and development of the transplantable C-6 glioma cells inoculated in rats by retinoids and carotenoidsCancer Letters, 1989
- RETINOIC ACID THERAPY FOR PROMYELOCYTIC LEUKAEMIAThe Lancet, 1989
- Chemotherapy for malignant gliomasJournal of Neurosurgery, 1988
- Effects of retinoic acid on expression of the transformed phenotype in C6 glioma cellsLife Sciences, 1987
- Mechanism of action of retinoidsJournal of the American Academy of Dermatology, 1986
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomasJournal of Neurosurgery, 1978
- Effects of retinoic acid on the immune system: Stimulation of T killer cell inductionEuropean Journal of Immunology, 1978